PLAGER, Circuit Judge. This is an appeal from a patent infringement action in which Key Pharmaceuticals, Inc. (“Key”) charged Hereon Laboratories Corporation (“Hereon”) with infringement of its U.S. Patent No. 5,186,938 (“ ’938 patent” or “the patent”). Hereon, in addition to denying infringement, counterclaimed that the patent is invalid and…
Read the full opinion (source) ↗
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Citation figures are counts of later citing opinions in our corpus and may be incomplete; always read and Shepardize the full opinion before relying on it.